SMTL ID : 4irs.1

Structure of the mouse CD1d-PyrC-alpha-GalCer-iNKT TCR complex

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.80 Å
Oligo State
hetero-1-1-1-1-mer
Ligands
1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x 1LA: N-[(2S,3S,4R)-3,4-dihydroxy-1-{[6-O-(pyridin-4-ylcarbamoyl)-alpha-D-galactopyranosyl]oxy}octadecan-2-yl]hexacosanamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Aspeslagh, S. et al., Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection. J.Immunol. (2013)
Release Date
2013-09-04
Peptides
Antigen-presenting glycoprotein CD1d1: A
Beta-2-microglobulin: B
Valpha14 (mouse variable domain, human constant domain): C
Vbeta8.2 (mouse variable domain, human constant domain): D
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
D

Antigen-presenting glycoprotein CD1d1

Beta-2-microglobulin

Valpha14 (mouse variable domain, human constant domain)

Vbeta8.2 (mouse variable domain, human constant domain)

Related Entries With Identical Sequence

1p4l.1 | 1u58.1 | 1z5l.1 | 1z5l.2 | 1z5l.3 | 2akr.1 | 2akr.2 | 2akr.3 | 2akr.4 | 2fik.1 | 2gaz.1 | 2q7y.1 | 2q7y.2 | 3arb.1 | 3ard.1 | 3are.1 | 3arf.1 | 3arg.1 | 3au1.1 | 3c8k.1 | 3g08.1 | 3gml.1 | 3gmm.1 | 3gmn.1 | 3gmo.1 | 3gmp.1 | 3gmq.1 | 3gmr.1 | 3he6.1 | 3he7.1  more...